Alzheimers Dement

ISSN	1552-5279
ISSN-L	1552-5260
IUID	82a9e46fa07546b28664a77de7a51b59
Modified	2020-11-27T13:12:55.586Z
Created	2018-12-05T09:16:52.012Z

Year 2025

DOI Crossref

A conditional two‐step approach for detecting Lewy Body pathology: smell function testing and α‐synuclein seed amplification

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 21 (S2) - [2025-12-00; online 2025-12-26]

PubMed DOI Crossref

Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data.

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

Alzheimers Dement 21 (2) e14600 [2025-02-00; online 2025-02-22]

PubMed DOI Crossref

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis.

Canal-Garcia A, Branca RM, Francis PT, ..., Pereira JB, Bereczki E

Alzheimers Dement 21 (1) e14375 [2025-01-00; online 2024-12-23]

Year 2024

DOI Crossref

Individual variation in proteomic cascades along the Alzheimer’s disease spectrum

Vogel JW, Vilkaite G, Binette AP, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Data‐driven progression patterns of Aβ, tau, α‐synuclein and vascular pathology in a clinical population

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

The mTOR‐4E‐BP1 axis controls microglia inflammatory and neurodegenerative responses

Bermudez S, Choi J, Kim S, ..., Healy LM, Sonenberg N

Alzheimers Dement 20 (S1) - [2024-12-00; online 2025-01-03]

DOI Crossref

Data‐driven progression patterns of Aβ, tau, α‐synuclein and vascular pathology in a clinical population

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Alzheimers Dement 20 (S9) - [2024-12-00; online 2025-01-09]

DOI Crossref

Improved precision of Alzheimer’s disease fluid biomarkers when using Amyloid‐β40 or non‐phosphorylated tau as a reference

Karlsson L, Janelidze S, Horie K, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Regional Amyloid Load Predicts Tau and Atrophy Dynamics

Chaggar P, Vogel JW, Binette AP, ..., Hansson O, Goriely A

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Impact of regional MAPT, APOE, and Aβ on tau propagation in Alzheimer’s disease: Insights from a connectome‐based simulation model

Xiao Y, Strandberg O, Bazinet V, ..., Hansson O, Vogel JW

Alzheimers Dement 20 (S8) - [2024-12-00; online 2025-01-09]

DOI Crossref

Proteomics analysis characterizing new markers related to Aβ plaques and tau tangles pathologies

Binette AP, Wennström M, Strandberg O, ..., Vogel JW, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Unlocking Tau PET Accessibility: a Machine Learning‐Based Prediction of Tau Pathology from Plasma, MRI and Clinical Variables

Karlsson L, Vogel JW, Strandberg O, ..., Mattsson‐Carlgren N, Hansson O

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Visual classification of tau‐PET detects four subtypes with different long‐term outcomes

Boccalini C, Mathoux G, Hristovska I, ..., Vogel JW, Garibotto V

Alzheimers Dement 20 (S2) - [2024-12-00; online 2025-01-09]

DOI Crossref

Visual classification of tau‐PET detects four subtypes with different long‐term outcomes

Boccalini C, Mathoux G, Hristovska I, ..., Vogel JW, Garibotto V

Alzheimers Dement 20 (S9) - [2024-12-00; online 2025-01-09]

Year 2023

DOI Crossref

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s

Salvadó G, Horie K, Barthélemy NR, ..., Bateman RJ, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Proteomics Analysis Identifying New Markers Related to Alzheimer’s Disease Pathology In Vivo

Binette AP, Salvadó G, Spotorno N, ..., Janelidze S, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Identification of Distinct and Shared Biomarkers in Cerebral Small Vessel Disease (SVD) through Proteomic Profiling of Cerebrospinal Fluid

Hristovska I, Kumar A, Binette AP, ..., Vogel JW, Hansson O

Alzheimers Dement 19 (S24) - [2023-12-00; online 2023-12-25]

DOI Crossref

Uncovering distinct spatial‐temporal trajectories of Lewy‐type α‐synuclein pathology: a Subtype and Stage Inference model analysis

Mastenbroek SE, Vogel JW, Collij LE, ..., Beach TG, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI Crossref

Shared and disparate transcriptomic signatures associated with cortical atrophy change in genetic behavioral variant frontotemporal degeneration

Shen T, Vogel JW, Van Deerlin VM, ..., Irwin DJ, McMillan CT

Alzheimers Dement 19 (S12) - [2023-12-00; online 2023-12-25]

DOI Crossref

Relation of different CSF biosignatures to clinical phenotypes in a memory clinic cohort

Alanko V, Mravinacová S, Kivipelto M, ..., Nilsson P, Sandebring‐Matton A

Alzheimers Dement 19 (S2) - [2023-06-00; online 2023-06-16]

Year 2016

PubMed DOI Crossref

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

Bereczki E, Francis PT, Howlett D, ..., Ballard C, Aarsland D

Alzheimers Dement 12 (11) 1149-1158 [2016-11-00; online 2016-05-22]

Affiliated researcher

DOI Crossref

P2‐064: Identification of Differentially Expressed Proteins in Alzheimer's Disease Through The Screening of The Protein Content of The Prefrontal Cortex of Alzheimer's Disease Patients Using Protein Microarrays

San Segundo-Acosta P, Garranzo-Asensio M, Montero-Calle A, ..., Villalba M, Barderas R

Alzheimers Dement 12 (7S_Part_13) - [2016-07-00; online 2016-07-00]